[8-K] Neuphoria Therapeutics Inc. Reports Material Event

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

Analyzing...

07/18/2025 - 05:00 PM

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Neuphoria Therapeutics Inc

#8931 Ranked by Market Cap

N/A Ranked by Dividends

May 27, 2025

May 20, 2025

Apr 15, 2025

Mar 3, 2025

Feb 12, 2025

Market Cap 14.29M

Float 1.63M

Insiders Ownership 377.45%

Institutions Ownership 66.94%

Short Percent 4.09%

Industry Biotechnology

Sector Pharmaceutical Preparations

Website Link

Country United States

City BURLINGTON